INTERNATIONAL PATENT: NEUROLAMBDA THERAPEUTICS, INC. FILES APPLICATION FOR "HETEROARYL COMPOUNDS USEFUL AS TYK2 INHIBITORS"

GENEVA, May 12 -- NEUROLAMBDA THERAPEUTICS, INC. (1 Broadway14th FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/052689) for "HETEROARYL COMPOUNDS USEFUL AS TYK2 INHIBITORS" on Oct 27, 2025. With publication no. WO/2026/096385, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIM, Byungchan (c/o NeuroLambda Therapeutics, Inc.1 Broadway14th FloorCambridge, Massachusetts 02142), MONDAL, Sayan (c/o NeuroLambda Therapeutics, Inc.1 Broadway14th FloorCambridge, Massachusetts 02142), NOWAK, Pawel (c/o ...